▶ 調査レポート

ウシ血漿誘導体の世界市場レポート2020

• 英文タイトル:Global Bovine Blood Plasma Derivatives Sales Market Report 2020

が調査・発行した産業分析レポートです。ウシ血漿誘導体の世界市場レポート2020 / Global Bovine Blood Plasma Derivatives Sales Market Report 2020 / MRC2102QY2116資料のイメージです。• レポートコード:MRC2102QY2116
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、140ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:材料、化学
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界のウシ血漿誘導体市場について種類別(ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他)、用途別(科学研究、工業生産、飼料、その他)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ウシ血漿誘導体市場の概要
・世界の主要地域別ウシ血漿誘導体市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のウシ血漿誘導体市場規模2015-2026:種類別(ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他)
・世界のウシ血漿誘導体市場規模2015-2026:用途別(科学研究、工業生産、飼料、その他)
・ウシ血漿誘導体の米国市場規模2015-2020
・ウシ血漿誘導体のヨーロッパ市場規模2015-2020
・ウシ血漿誘導体の中国市場規模2015-2020
・ウシ血漿誘導体の日本市場規模2015-2020
・ウシ血漿誘導体の東南アジア市場規模2015-2020
・ウシ血漿誘導体のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・ウシ血漿誘導体の製造コスト分析
・販売チャネル、流通業者、顧客
・ウシ血漿誘導体の市場動向・機会・課題
・調査の結論

Bovine Blood Plasma Derivatives covers different types of bovine blood plasma derivatives,and typically used in scientific research and industrial production.
Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals and Bovogen are major players in this market. Relying on blood supply from around the world, Thermo Fisher, GE Healthcare and Merck (Sigma-Aldrich) are the world’s three giants. In 2017, Merck (Sigma-Aldrich) is the world leader with a market share of 22.62%

Market Analysis and Insights: Global Bovine Blood Plasma Derivatives Market
The global Bovine Blood Plasma Derivatives market size is projected to reach US$ 2522.7 million by 2026, from US$ 1937.2 million in 2020, at a CAGR of 4.5% during 2021-2026.

Global Bovine Blood Plasma Derivatives Scope and Market Size
The global Bovine Blood Plasma Derivatives market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bovine Blood Plasma Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Bovine Blood Plasma Derivatives market is segmented into
Bovine Serum
FBS
Bovine Serum Albumin
Fibrinogen
Protein Ingredient
Other

Segment by Application, the Bovine Blood Plasma Derivatives market is segmented into
Scientific Research
Industrial Production
Feed
Others

The Bovine Blood Plasma Derivatives market is analysed and market size information is provided by regions (countries). Segment by Application, the Bovine Blood Plasma Derivatives market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Bovine Blood Plasma Derivatives Market Share Analysis
Bovine Blood Plasma Derivatives market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bovine Blood Plasma Derivatives business, the date to enter into the Bovine Blood Plasma Derivatives market, Bovine Blood Plasma Derivatives product introduction, recent developments, etc.

The major vendors covered:
Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac

レポート目次

1 Bovine Blood Plasma Derivatives Market Overview
1.1 Bovine Blood Plasma Derivatives Product Scope
1.2 Bovine Blood Plasma Derivatives Segment by Type
1.2.1 Global Bovine Blood Plasma Derivatives Sales by Type (2020-2026)
1.2.2 Bovine Serum
1.2.3 FBS
1.2.4 Bovine Serum Albumin
1.2.5 Fibrinogen
1.2.6 Protein Ingredient
1.2.7 Other
1.3 Bovine Blood Plasma Derivatives Segment by Application
1.3.1 Global Bovine Blood Plasma Derivatives Sales Comparison by Application (2020-2026)
1.3.2 Scientific Research
1.3.3 Industrial Production
1.3.4 Feed
1.3.5 Others
1.4 Bovine Blood Plasma Derivatives Market Estimates and Forecasts (2015-2026)
1.4.1 Global Bovine Blood Plasma Derivatives Sales Growth Rate (2015-2026)
1.4.2 Global Bovine Blood Plasma Derivatives Revenue and Growth Rate (2015-2026)
1.4.3 Global Bovine Blood Plasma Derivatives Price Trends (2015-2026)

2 Bovine Blood Plasma Derivatives Estimate and Forecast by Region
2.1 Global Bovine Blood Plasma Derivatives Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Bovine Blood Plasma Derivatives Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Bovine Blood Plasma Derivatives Sales Market Share by Region (2015-2020)
2.2.2 Global Bovine Blood Plasma Derivatives Revenue Market Share by Region (2015-2020)
2.3 Global Bovine Blood Plasma Derivatives Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Bovine Blood Plasma Derivatives Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Bovine Blood Plasma Derivatives Estimates and Projections (2015-2026)
2.4.2 Europe Bovine Blood Plasma Derivatives Estimates and Projections (2015-2026)
2.4.3 China Bovine Blood Plasma Derivatives Estimates and Projections (2015-2026)
2.4.4 Japan Bovine Blood Plasma Derivatives Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Bovine Blood Plasma Derivatives Estimates and Projections (2015-2026)
2.4.6 India Bovine Blood Plasma Derivatives Estimates and Projections (2015-2026)
3 Global Bovine Blood Plasma Derivatives Competition Landscape by Players
3.1 Global Top Bovine Blood Plasma Derivatives Players by Sales (2015-2020)
3.2 Global Top Bovine Blood Plasma Derivatives Players by Revenue (2015-2020)
3.3 Global Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bovine Blood Plasma Derivatives as of 2019)
3.4 Global Bovine Blood Plasma Derivatives Average Price by Company (2015-2020)
3.5 Manufacturers Bovine Blood Plasma Derivatives Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Bovine Blood Plasma Derivatives Players (Opinion Leaders)
4 Global Bovine Blood Plasma Derivatives Market Size by Type
4.1 Global Bovine Blood Plasma Derivatives Historic Market Review by Type (2015-2020)
4.1.1 Global Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
4.1.2 Global Bovine Blood Plasma Derivatives Revenue Market Share by Type (2015-2020)
4.1.3 Global Bovine Blood Plasma Derivatives Price by Type (2015-2020)
4.2 Global Bovine Blood Plasma Derivatives Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Type (2021-2026)
4.2.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Type (2021-2026)
4.2.3 Global Bovine Blood Plasma Derivatives Price Forecast by Type (2021-2026)
5 Global Bovine Blood Plasma Derivatives Market Size by Application
5.1 Global Bovine Blood Plasma Derivatives Historic Market Review by Application (2015-2020)
5.1.1 Global Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)
5.1.2 Global Bovine Blood Plasma Derivatives Revenue Market Share by Application (2015-2020)
5.1.3 Global Bovine Blood Plasma Derivatives Price by Application (2015-2020)
5.2 Global Bovine Blood Plasma Derivatives Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Application (2021-2026)
5.2.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Application (2021-2026)
5.2.3 Global Bovine Blood Plasma Derivatives Price Forecast by Application (2021-2026)

6 United States Bovine Blood Plasma Derivatives Market Facts & Figures
6.1 United States Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
6.2 United States Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
6.3 United States Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)

7 Europe Bovine Blood Plasma Derivatives Market Facts & Figures
7.1 Europe Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
7.2 Europe Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
7.3 Europe Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)

8 China Bovine Blood Plasma Derivatives Market Facts & Figures
8.1 China Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
8.2 China Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
8.3 China Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)

9 Japan Bovine Blood Plasma Derivatives Market Facts & Figures
9.1 Japan Bovine Blood Plasma Derivatives Sales Market Share by Company (3015-3030)
9.2 Japan Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
9.3 Japan Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)

10 Southeast Asia Bovine Blood Plasma Derivatives Market Facts & Figures
10.1 Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)

11 India Bovine Blood Plasma Derivatives Market Facts & Figures
11.1 India Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
11.2 India Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
11.3 India Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Bovine Blood Plasma Derivatives Business
12.1 Thermo Fisher
12.1.1 Thermo Fisher Corporation Information
12.1.2 Thermo Fisher Business Overview
12.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Thermo Fisher Bovine Blood Plasma Derivatives Products Offered
12.1.5 Thermo Fisher Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Corporation Information
12.2.2 GE Healthcare Business Overview
12.2.3 GE Healthcare Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GE Healthcare Bovine Blood Plasma Derivatives Products Offered
12.2.5 GE Healthcare Recent Development
12.3 Merck (Sigma-Aldrich)
12.3.1 Merck (Sigma-Aldrich) Corporation Information
12.3.2 Merck (Sigma-Aldrich) Business Overview
12.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Products Offered
12.3.5 Merck (Sigma-Aldrich) Recent Development
12.4 Moregate BioTech
12.4.1 Moregate BioTech Corporation Information
12.4.2 Moregate BioTech Business Overview
12.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Moregate BioTech Bovine Blood Plasma Derivatives Products Offered
12.4.5 Moregate BioTech Recent Development
12.5 Gemini
12.5.1 Gemini Corporation Information
12.5.2 Gemini Business Overview
12.5.3 Gemini Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Gemini Bovine Blood Plasma Derivatives Products Offered
12.5.5 Gemini Recent Development
12.6 Atlanta Biologicals
12.6.1 Atlanta Biologicals Corporation Information
12.6.2 Atlanta Biologicals Business Overview
12.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Atlanta Biologicals Bovine Blood Plasma Derivatives Products Offered
12.6.5 Atlanta Biologicals Recent Development
12.7 Tissue Culture Biologicals
12.7.1 Tissue Culture Biologicals Corporation Information
12.7.2 Tissue Culture Biologicals Business Overview
12.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Products Offered
12.7.5 Tissue Culture Biologicals Recent Development
12.8 Bovogen
12.8.1 Bovogen Corporation Information
12.8.2 Bovogen Business Overview
12.8.3 Bovogen Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bovogen Bovine Blood Plasma Derivatives Products Offered
12.8.5 Bovogen Recent Development
12.9 Biowest
12.9.1 Biowest Corporation Information
12.9.2 Biowest Business Overview
12.9.3 Biowest Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biowest Bovine Blood Plasma Derivatives Products Offered
12.9.5 Biowest Recent Development
12.10 Internegocios
12.10.1 Internegocios Corporation Information
12.10.2 Internegocios Business Overview
12.10.3 Internegocios Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Internegocios Bovine Blood Plasma Derivatives Products Offered
12.10.5 Internegocios Recent Development
12.11 RMBIO
12.11.1 RMBIO Corporation Information
12.11.2 RMBIO Business Overview
12.11.3 RMBIO Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.11.4 RMBIO Bovine Blood Plasma Derivatives Products Offered
12.11.5 RMBIO Recent Development
12.12 Biological Industries
12.12.1 Biological Industries Corporation Information
12.12.2 Biological Industries Business Overview
12.12.3 Biological Industries Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Biological Industries Bovine Blood Plasma Derivatives Products Offered
12.12.5 Biological Industries Recent Development
12.13 VWR
12.13.1 VWR Corporation Information
12.13.2 VWR Business Overview
12.13.3 VWR Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.13.4 VWR Bovine Blood Plasma Derivatives Products Offered
12.13.5 VWR Recent Development
12.14 Corning
12.14.1 Corning Corporation Information
12.14.2 Corning Business Overview
12.14.3 Corning Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Corning Bovine Blood Plasma Derivatives Products Offered
12.14.5 Corning Recent Development
12.15 Serana
12.15.1 Serana Corporation Information
12.15.2 Serana Business Overview
12.15.3 Serana Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Serana Bovine Blood Plasma Derivatives Products Offered
12.15.5 Serana Recent Development
12.16 Lanzhou Minhai
12.16.1 Lanzhou Minhai Corporation Information
12.16.2 Lanzhou Minhai Business Overview
12.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Lanzhou Minhai Bovine Blood Plasma Derivatives Products Offered
12.16.5 Lanzhou Minhai Recent Development
12.17 Zhejiang Tianhang Biotechnology
12.17.1 Zhejiang Tianhang Biotechnology Corporation Information
12.17.2 Zhejiang Tianhang Biotechnology Business Overview
12.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Products Offered
12.17.5 Zhejiang Tianhang Biotechnology Recent Development
12.18 ExCell Bio
12.18.1 ExCell Bio Corporation Information
12.18.2 ExCell Bio Business Overview
12.18.3 ExCell Bio Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.18.4 ExCell Bio Bovine Blood Plasma Derivatives Products Offered
12.18.5 ExCell Bio Recent Development
12.19 Jin Yuan Kang
12.19.1 Jin Yuan Kang Corporation Information
12.19.2 Jin Yuan Kang Business Overview
12.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Jin Yuan Kang Bovine Blood Plasma Derivatives Products Offered
12.19.5 Jin Yuan Kang Recent Development
12.20 American Protein Company
12.20.1 American Protein Company Corporation Information
12.20.2 American Protein Company Business Overview
12.20.3 American Protein Company Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.20.4 American Protein Company Bovine Blood Plasma Derivatives Products Offered
12.20.5 American Protein Company Recent Development
12.21 Sonac
12.21.1 Sonac Corporation Information
12.21.2 Sonac Business Overview
12.21.3 Sonac Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Sonac Bovine Blood Plasma Derivatives Products Offered
12.21.5 Sonac Recent Development

13 Bovine Blood Plasma Derivatives Manufacturing Cost Analysis
13.1 Bovine Blood Plasma Derivatives Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bovine Blood Plasma Derivatives
13.4 Bovine Blood Plasma Derivatives Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bovine Blood Plasma Derivatives Distributors List
14.3 Bovine Blood Plasma Derivatives Customers

15 Market Dynamics
15.1 Bovine Blood Plasma Derivatives Market Trends
15.2 Bovine Blood Plasma Derivatives Opportunities and Drivers
15.3 Bovine Blood Plasma Derivatives Market Challenges
15.4 Bovine Blood Plasma Derivatives Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Bovine Blood Plasma Derivatives Sales (L) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Bovine Blood Plasma Derivatives Sales (L) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Bovine Blood Plasma Derivatives Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Bovine Blood Plasma Derivatives Sales (L) by Region (2015-2020)
Table 5. Global Bovine Blood Plasma Derivatives Sales Market Share by Region (2015-2020)
Table 6. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Bovine Blood Plasma Derivatives Revenue Share by Region (2015-2020)
Table 8. Global Bovine Blood Plasma Derivatives Sales (L) Forecast by Region (2021-2026)
Table 9. Global Bovine Blood Plasma Derivatives Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Bovine Blood Plasma Derivatives Revenue Share Forecast by Region (2021-2026)
Table 12. Global Bovine Blood Plasma Derivatives (L) of Key Companies (2015-2020)
Table 13. Global Bovine Blood Plasma Derivatives Sales Share by Company (2015-2020)
Table 14. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Bovine Blood Plasma Derivatives Revenue Share by Company (2015-2020)
Table 16. Global Bovine Blood Plasma Derivatives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bovine Blood Plasma Derivatives as of 2019)
Table 17. Global Bovine Blood Plasma Derivatives Average Price (USD/L) of Key Company (2015-2020)
Table 18. Manufacturers Bovine Blood Plasma Derivatives Manufacturing Sites and Area Served
Table 19. Manufacturers Bovine Blood Plasma Derivatives Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Bovine Blood Plasma Derivatives Players
Table 22. Global Bovine Blood Plasma Derivatives Sales (L) by Type (2015-2020)
Table 23. Global Bovine Blood Plasma Derivatives Sales Share by Type (2015-2020)
Table 24. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Bovine Blood Plasma Derivatives Price (L) by Type (2015-2020)
Table 26. Global Bovine Blood Plasma Derivatives Sales Share by Type (2021-2026)
Table 27. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Bovine Blood Plasma Derivatives Revenue Share by Type (2021-2026)
Table 29. Global Bovine Blood Plasma Derivatives Price (L) by Type (2021-2026)
Table 30. Global Bovine Blood Plasma Derivatives Sales (L) by Application (2015-2020)
Table 31. Global Bovine Blood Plasma Derivatives Sales Share by Application (2015-2020)
Table 32. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Bovine Blood Plasma Derivatives Price (L) by Application (2015-2020)
Table 34. Global Bovine Blood Plasma Derivatives Sales (L) by Application (2021-2026)
Table 35. Global Bovine Blood Plasma Derivatives Sales Share by Application (2021-2026)
Table 36. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Bovine Blood Plasma Derivatives Revenue Share by Application (2021-2026)
Table 38. Global Bovine Blood Plasma Derivatives Price (L) by Application (2021-2026)
Table 39. United States Bovine Blood Plasma Derivatives Sales (L) by Company (2015-2020)
Table 40. United States Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
Table 41. United States Bovine Blood Plasma Derivatives Sales (L) by Type (2015-2020)
Table 42. United States Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
Table 43. United States Bovine Blood Plasma Derivatives Sales (L) by Application (2015-2020)
Table 44. United States Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)
Table 45. Europe Bovine Blood Plasma Derivatives Sales (L) by Company (2015-2020)
Table 46. Europe Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
Table 47. Europe Bovine Blood Plasma Derivatives Sales (L) by Type (2015-2020)
Table 48. Europe Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
Table 49. Europe Bovine Blood Plasma Derivatives Sales (L) by Application (2015-2020)
Table 50. Europe Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
Table 51. China Bovine Blood Plasma Derivatives Sales (L) by Company (2015-2020)
Table 52. China Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
Table 53. China Bovine Blood Plasma Derivatives Sales (L) by Type (2015-2020)
Table 54. China Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
Table 55. China Bovine Blood Plasma Derivatives Sales (L) by Application (2015-2020)
Table 56. China Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)
Table 57. Japan Bovine Blood Plasma Derivatives Sales (L) by Company (2015-2020)
Table 58. Japan Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
Table 59. Japan Bovine Blood Plasma Derivatives Sales (L) by Type (2015-2020)
Table 60. Japan Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
Table 61. Japan Bovine Blood Plasma Derivatives Sales (L) by Application (2015-2020)
Table 62. Japan Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Bovine Blood Plasma Derivatives Sales (L) by Company (2015-2020)
Table 64. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Bovine Blood Plasma Derivatives Sales (L) by Type (2015-2020)
Table 66. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Bovine Blood Plasma Derivatives Sales (L) by Type (2015-2020)
Table 68. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)
Table 69. India Bovine Blood Plasma Derivatives Sales (L) by Company (2015-2020)
Table 70. India Bovine Blood Plasma Derivatives Sales Market Share by Company (2015-2020)
Table 71. India Bovine Blood Plasma Derivatives Sales (L) by Type (2015-2020)
Table 72. India Bovine Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
Table 73. India Bovine Blood Plasma Derivatives Sales (L) by Application (2015-2020)
Table 74. India Bovine Blood Plasma Derivatives Sales Market Share by Application (2015-2020)
Table 75. Thermo Fisher Corporation Information
Table 76. Thermo Fisher Description and Business Overview
Table 77. Thermo Fisher Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 78. Thermo Fisher Bovine Blood Plasma Derivatives Product
Table 79. Thermo Fisher Recent Development
Table 80. GE Healthcare Corporation Information
Table 81. GE Healthcare Description and Business Overview
Table 82. GE Healthcare Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 83. GE Healthcare Bovine Blood Plasma Derivatives Product
Table 84. GE Healthcare Recent Development
Table 85. Merck (Sigma-Aldrich) Corporation Information
Table 86. Merck (Sigma-Aldrich) Description and Business Overview
Table 87. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 88. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Product
Table 89. Merck (Sigma-Aldrich) Recent Development
Table 90. Moregate BioTech Corporation Information
Table 91. Moregate BioTech Description and Business Overview
Table 92. Moregate BioTech Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 93. Moregate BioTech Bovine Blood Plasma Derivatives Product
Table 94. Moregate BioTech Recent Development
Table 95. Gemini Corporation Information
Table 96. Gemini Description and Business Overview
Table 97. Gemini Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 98. Gemini Bovine Blood Plasma Derivatives Product
Table 99. Gemini Recent Development
Table 100. Atlanta Biologicals Corporation Information
Table 101. Atlanta Biologicals Description and Business Overview
Table 102. Atlanta Biologicals Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 103. Atlanta Biologicals Bovine Blood Plasma Derivatives Product
Table 104. Atlanta Biologicals Recent Development
Table 105. Tissue Culture Biologicals Corporation Information
Table 106. Tissue Culture Biologicals Description and Business Overview
Table 107. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 108. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Product
Table 109. Tissue Culture Biologicals Recent Development
Table 110. Bovogen Corporation Information
Table 111. Bovogen Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 112. Bovogen Description and Business Overview
Table 113. Bovogen Bovine Blood Plasma Derivatives Product
Table 114. Bovogen Recent Development
Table 115. Biowest Corporation Information
Table 116. Biowest Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 117. Biowest Description and Business Overview
Table 118. Biowest Bovine Blood Plasma Derivatives Product
Table 119. Biowest Recent Development
Table 120. Internegocios Corporation Information
Table 121. Internegocios Description and Business Overview
Table 122. Internegocios Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 123. Internegocios Bovine Blood Plasma Derivatives Product
Table 124. Internegocios Recent Development
Table 125. RMBIO Corporation Information
Table 126. RMBIO Description and Business Overview
Table 127. RMBIO Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 128. RMBIO Bovine Blood Plasma Derivatives Product
Table 129. RMBIO Recent Development
Table 130. Biological Industries Corporation Information
Table 131. Biological Industries Description and Business Overview
Table 132. Biological Industries Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 133. Biological Industries Bovine Blood Plasma Derivatives Product
Table 134. Biological Industries Recent Development
Table 135. VWR Corporation Information
Table 136. VWR Description and Business Overview
Table 137. VWR Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 138. VWR Bovine Blood Plasma Derivatives Product
Table 139. VWR Recent Development
Table 140. Corning Corporation Information
Table 141. Corning Description and Business Overview
Table 142. Corning Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 143. Corning Bovine Blood Plasma Derivatives Product
Table 144. Corning Recent Development
Table 145. Serana Corporation Information
Table 146. Serana Description and Business Overview
Table 147. Serana Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 148. Serana Bovine Blood Plasma Derivatives Product
Table 149. Serana Recent Development
Table 150. Lanzhou Minhai Corporation Information
Table 151. Lanzhou Minhai Description and Business Overview
Table 152. Lanzhou Minhai Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 153. Lanzhou Minhai Bovine Blood Plasma Derivatives Product
Table 154. Lanzhou Minhai Recent Development
Table 155. Zhejiang Tianhang Biotechnology Corporation Information
Table 156. Zhejiang Tianhang Biotechnology Description and Business Overview
Table 157. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 158. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Product
Table 159. Zhejiang Tianhang Biotechnology Recent Development
Table 160. ExCell Bio Corporation Information
Table 161. ExCell Bio Description and Business Overview
Table 162. ExCell Bio Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 163. ExCell Bio Bovine Blood Plasma Derivatives Product
Table 164. ExCell Bio Recent Development
Table 165. Jin Yuan Kang Corporation Information
Table 166. Jin Yuan Kang Description and Business Overview
Table 167. Jin Yuan Kang Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 168. Jin Yuan Kang Bovine Blood Plasma Derivatives Product
Table 169. Jin Yuan Kang Recent Development
Table 170. American Protein Company Corporation Information
Table 171. American Protein Company Description and Business Overview
Table 172. American Protein Company Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 173. American Protein Company Bovine Blood Plasma Derivatives Product
Table 174. American Protein Company Recent Development
Table 175. Sonac Corporation Information
Table 176. Sonac Description and Business Overview
Table 177. Sonac Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 178. Sonac Bovine Blood Plasma Derivatives Product
Table 179. Sonac Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Bovine Blood Plasma Derivatives Distributors List
Table 183. Bovine Blood Plasma Derivatives Customers List
Table 184. Bovine Blood Plasma Derivatives Market Key Trends
Table 185. Bovine Blood Plasma Derivatives Key Opportunities and Drivers
Table 186. Bovine Blood Plasma Derivatives Market Challenges
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Bovine Blood Plasma Derivatives Product Picture
Figure 2. Global Bovine Blood Plasma Derivatives Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bovine Blood Plasma Derivatives Market Share by Application in 2020 & 2026
Figure 6. Scientific Research Examples
Figure 7. Industrial Production Examples
Figure 8. Feed Examples
Figure 9. Others Examples
Figure 10. Global Bovine Blood Plasma Derivatives Sales (L) Growth Rate (2015-2026)
Figure 11. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Bovine Blood Plasma Derivatives Price Trends Growth Rate (2015-2026) (USD/L)
Figure 13. Global Bovine Blood Plasma Derivatives Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Bovine Blood Plasma Derivatives Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Bovine Blood Plasma Derivatives Sales (L) Growth Rate (2015-2026)
Figure 17. Europe Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Bovine Blood Plasma Derivatives Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Bovine Blood Plasma Derivatives Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Bovine Blood Plasma Derivatives Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Bovine Blood Plasma Derivatives Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Bovine Blood Plasma Derivatives Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Bovine Blood Plasma Derivatives Players Market Share by Revenue in Bovine Blood Plasma Derivatives 2015 & 2019
Figure 28. Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Bovine Blood Plasma Derivatives Revenue Share by Type (2015-2020)
Figure 30. Global Bovine Blood Plasma Derivatives Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Bovine Blood Plasma Derivatives Revenue Share by Application (2015-2020)
Figure 32. Global Bovine Blood Plasma Derivatives Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Bovine Blood Plasma Derivatives Sales Market Share by Type in 2019
Figure 34. United States Bovine Blood Plasma Derivatives Sales Market Share by Type in 2019
Figure 35. Europe Bovine Blood Plasma Derivatives Sales Market Share by Company in 2019
Figure 36. Europe Bovine Blood Plasma Derivatives Sales Market Share by Type in 2019
Figure 37. Europe Bovine Blood Plasma Derivatives Sales Market Share by Application in 2019
Figure 38. China Bovine Blood Plasma Derivatives Sales Market Share by Company in 2019
Figure 39. China Bovine Blood Plasma Derivatives Sales Market Share by Type in 2019
Figure 40. China Bovine Blood Plasma Derivatives Sales Market Share by Application in 2019
Figure 41. Japan Bovine Blood Plasma Derivatives Sales Market Share by Company in 2019
Figure 42. Japan Bovine Blood Plasma Derivatives Sales Market Share by Type in 2019
Figure 43. Japan Bovine Blood Plasma Derivatives Sales Market Share by Application in 2019
Figure 44. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Company in 2019
Figure 45. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Type in 2019
Figure 46. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Application in 2019
Figure 47. India Bovine Blood Plasma Derivatives Sales Market Share by Company in 2019
Figure 48. India Bovine Blood Plasma Derivatives Sales Market Share by Type in 2019
Figure 49. India Bovine Blood Plasma Derivatives Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Bovine Blood Plasma Derivatives
Figure 52. Manufacturing Process Analysis of Bovine Blood Plasma Derivatives
Figure 53. Bovine Blood Plasma Derivatives Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed